Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

 Full screen view
Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 1 782 223 0.5535 0.4069 0.2852 0.2828
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 2 529 145 0.3802 0.4069 0.2741 0.2828
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 3 408 118 0.2871 0.4069 0.2892 0.2828
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 1 644 178 0.4614 0.3703 0.2764 0.2742
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 2 511 154 0.3535 0.3703 0.3014 0.2742
MMAC-SF Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 3 396 97 0.2960 0.3703 0.2449 0.2742
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 1 582 234 0.3446 0.3729 0.4021 0.4100
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 2 624 248 0.3723 0.3729 0.3974 0.4100
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 3 713 307 0.4020 0.3729 0.4306 0.4100
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 1 543 184 0.3554 0.4000 0.3389 0.3246
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 2 617 189 0.4238 0.4000 0.3063 0.3246
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 3 633 208 0.4208 0.4000 0.3286 0.3246
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 1 746 190 0.5505 0.3937 0.2547 0.2879
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 2 553 190 0.3594 0.3937 0.3436 0.2879
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 3 373 99 0.2713 0.3937 0.2654 0.2879
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 1 584 174 0.4059 0.3373 0.2979 0.2733
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 2 450 131 0.3158 0.3373 0.2911 0.2733
MMAC-SF Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 3 381 88 0.2901 0.3373 0.2310 0.2733
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 1 477 211 0.2634 0.2795 0.4423 0.4515
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 2 547 258 0.2861 0.2795 0.4717 0.4515
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 3 522 230 0.2891 0.2795 0.4406 0.4515
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 1 389 120 0.2663 0.2574 0.3085 0.3200
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 2 366 118 0.2455 0.2574 0.3224 0.3200
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 3 392 129 0.2604 0.2574 0.3291 0.3200
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 1.0000
uM
 72
hr
 1 546 177 0.3653 0.2710 0.3242 0.3368